| Date Filed | Type | Description |
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Klompas Neil A (COO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 1,525 shares
@ $4.51, valued at
$6.9k
|
|
| 03/11/2022 |
4
| Astle Christopher (SVP & CFO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 125,000 options to buy
@ $7, valued at
$875k
|
|
| 03/11/2022 |
4
| Klompas Neil A (COO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Sold 2,979 shares
@ $6.88, valued at
$20.5k
Exercised 2,500 restricted stock units
@ $0
Exercised 2,708 restricted stock units
@ $0
Granted 200,000 options to buy
@ $7, valued at
$1.4M
|
|
| 03/11/2022 |
4
| Josephson Neil (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Exercised 729 restricted stock units
@ $0
Exercised 1,666 restricted stock units
@ $0 |
|
| 03/04/2022 |
3
| Astle Christopher (SVP & CFO) has filed a Form 3 on Zymeworks Inc. |
| 01/18/2022 |
4
| Galbraith Kenneth (Chair, President & CEO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 500,000 options to buy
@ $14.97, valued at
$7.5M
|
|
| 01/18/2022 |
3
| Galbraith Kenneth (Chair, President & CEO) has filed a Form 3 on Zymeworks Inc. |
| 01/11/2022 |
4
| Josephson Neil (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Bought 1,400 shares
@ $14.27, valued at
$20k
Bought 3,600 shares
@ $14.28, valued at
$51.4k
|
|
| 01/07/2022 |
4
| Josephson Neil (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 65 shares
@ $13.94, valued at
$906.1 |
|
| 01/07/2022 |
4
| Polverino Anthony J. (Chief Scientific Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 74 shares
@ $13.94, valued at
$1k
|
|
| 01/07/2022 |
4
| Klompas Neil A (COO & CFO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 277 shares
@ $13.94, valued at
$3.9k
|
|
| 11/12/2021 |
4
| Josephson Neil (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 105,943 options to buy
@ $21.18, valued at
$2.2M
Granted 17,657 restricted stock units
@ $0 |
|
| 09/02/2021 |
4
| Polverino Anthony J. (Chief Scientific Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Exercised 4,900 options to buy
@ $15, valued at
$73.5k
|
|
| 07/16/2021 |
4
| Tehrani Ali (CEO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Exercised 3,800 shares
@ $4.2713, valued at
$16.2k
Sold 3,800 shares
@ $36, valued at
$136.8k
Exercised 41,191 shares
@ $4.2643, valued at
$175.7k
Sold 41,191 shares
@ $36, valued at
$1.5M
Exercised 3,800 options to buy
@ $0
Exercised 41,191 options to buy
@ $0 |
|
| 07/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| O'Driscoll Kathryn (Chief People Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 510 shares
@ $29.49, valued at
$15k
|
|
| 07/08/2021 |
4
| Polverino Anthony J. (Chief Scientific Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 454 shares
@ $29.49, valued at
$13.4k
|
|
| 07/08/2021 |
4
| Klompas Neil A (CFO) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 299 shares
@ $29.49, valued at
$8.8k
|
|
| 07/08/2021 |
4
| Priour James (Chief Commercial Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 510 shares
@ $29.49, valued at
$15k
|
|
| 07/08/2021 |
4
| Josephson Neil (Interim Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 461 shares
@ $29.49, valued at
$13.6k
|
|
| 05/25/2021 |
3
| Josephson Neil (Interim Chief Medical Officer) has filed a Form 3 on Zymeworks Inc. |
| 05/07/2021 |
4
| Neu Kelvin (Director) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 9,000 options to buy
@ $29.49, valued at
$265.4k
|
|
| 05/07/2021 |
4
| Hillan Kenneth J. (Director) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 9,000 options to buy
@ $29.49, valued at
$265.4k
|
|
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Sacks Natalie (Director) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 9,000 options to buy
@ $29.49, valued at
$265.4k
|
|
| 05/07/2021 |
4
| Cox Troy (Director) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 9,000 options to buy
@ $29.49, valued at
$265.4k
|
|
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Zoth Lota S. (Director) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 9,000 options to buy
@ $29.49, valued at
$265.4k
|
|
| 04/13/2021 |
4
| Priour James (Chief Commercial Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Sold 950 shares
@ $27.9296, valued at
$26.5k
Exercised 2,266 restricted stock units
@ $0 |
|
| 03/17/2021 |
4
| O'Driscoll Kathryn (Chief People Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Sold 786 shares
@ $34.72, valued at
$27.3k
Exercised 837 options to buy
@ $34.24, valued at
$28.7k
|
|
|